Penny and colleagues also reported that pancreatic ductal adenocarcinoma produced TAMs expressing both M1 (IL‐1β, IL6, and TNF‐α) and M2 (CD163, CD206, and Arg1) markers.27 This evidence concerns the gene CD163 and pancreatic ductal adenocarcinoma.